Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04283149Not ApplicableCompleted

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

Role: lead

NCT03499821Not ApplicableCompleted

Clinical Performance of a Phakic Intraocular Lens (IOL)

Role: lead

NCT04516772Not ApplicableCompleted

STAAR Visian Toric ICL Post-Approval Study

Role: lead

NCT05538754Not ApplicableCompleted

Post-Market Evaluation of the EVO ICL

Role: lead

NCT07291739Not ApplicableCompleted

A Clinical Evaluation of a Phakic Intraocular Lens

Role: lead

NCT01191515Unknown

Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study

Role: collaborator

NCT01088568Not ApplicableUnknown

Randomized, Prospective Comparison of the Outcome of Toric Implantable Contact Lens (TICL) and Q-LASIK for the Correction of Myopia With Astigmatism

Role: collaborator

All 7 trials loaded